← Leaderboards
Jie Sun
University Of Virginia
$22,468,243
Attributed
$24,539,066
Total exposure
13
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.6M · FY2012–25$5M$3.8M$2.5M$1.3M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$24,539,066 · 13
By mechanism
R01$22,733,137 · 9
R21$1,311,856 · 3
R56$494,073 · 1
Top collaborators
- William Gerald Teague3 shared
- Robert Vassallo3 shared
Most similar at University Of Virginia
Same institution · by research overlap
- Karen D Fairchild$4,901,510
- Sarah J Ratcliffe$6,997,529
- John Kattwinkel$2,588,940
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularLungResponseInfectionTissuesInfluenzavirusFutureImmunityMediatingInfluenzaT-LymphocyteVirus DiseasesViralCd8b1 GeneSignal TransductionPathogenT Cell ResponseMorbidity - Disease RateInflammationChronicExhibitsImmune ResponseCd8-Positive T-LymphocytesDesign
Grant awards (58)
Determinants of Convalescent and Vaccine-induced Mucosal Specific Immunity to SARS-CoV-2 and Variants of Concern in Children with Asthma$678,376
R01 · FY2025 · AI
Uncover mechanisms underlying the development of chronic lung sequelae post COVID-19$676,257
R01 · FY2025 · HL · contact PI
Host cellular network governing the development of post SARS-CoV-2 tissue sequelae$642,689
R01 · FY2025 · AI · contact PI
CD38, T cells and post viral lung sequelae during aging$639,740
R01 · FY2025 · AG · contact PI
Elucidating the roles of alveolar macrophage inflammation and self renewal during influenza infection$614,905
R01 · FY2025 · AG · contact PI
Determinants of Convalescent and Vaccine-induced Mucosal Specific Immunity to SARS-CoV-2 and Variants of Concern in Children with Asthma$697,498
R01 · FY2024 · AI
Uncover mechanisms underlying the development of chronic lung sequelae post COVID-19$662,044
R01 · FY2024 · HL · contact PI
Balancing protective immunity and chronic sequelae by resident CD8 T cells$569,694
R01 · FY2024 · AI · contact PI
Roles of tissue-resident helper T cells in mucosal immunity against influenzainfection$533,722
R01 · FY2024 · AI · contact PI
Molecular regulation of protective CD8 immunity against influenza infection$504,024
R01 · FY2024 · AI · contact PI
Elucidating the roles of alveolar macrophage inflammation and self renewal duringinfluenza infection$451,719
R01 · FY2024 · AG · contact PI
Uncover mechanisms underlying the development of chronic lung sequelae post COVID-19$720,284
R01 · FY2023 · HL · contact PI
Determinants of Convalescent and Vaccine-induced Mucosal Specific Immunity to SARS-CoV-2 and Variants of Concern in Children with Asthma$707,188
R01 · FY2023 · AI
Roles of tissue-resident helper T cells in mucosal immunity against influenzainfection$613,063
R01 · FY2023 · AI · contact PI
Balancing protective immunity and chronic sequelae by resident CD8 T cells$569,694
R01 · FY2023 · AI · contact PI
Molecular regulation of protective CD8 immunity against influenza infection$496,645
R01 · FY2023 · AI · contact PI
Elucidating the roles of alveolar macrophage inflammation and self renewal duringinfluenza infection$451,719
R01 · FY2023 · AG · contact PI
Roles of tissue-resident helper T cells in mucosal immunity against influenzainfection$616,876
R01 · FY2022 · AI · contact PI
Balancing protective immunity and chronic sequelae by resident CD8 T cells$569,694
R01 · FY2022 · AI · contact PI
Molecular regulation of protective CD8 immunity against influenza infection$501,204
R01 · FY2022 · AI · contact PI
Elucidating the roles of alveolar macrophage inflammation and self renewal duringinfluenza infection$463,182
R01 · FY2022 · AG · contact PI
Balancing protective immunity and chronic sequelae by resident CD8 T cells$560,876
R01 · FY2021 · AI · contact PI
Roles of tissue-resident helper T cells in mucosal immunity against influenzainfection$513,151
R01 · FY2021 · AI · contact PI
Molecular regulation of protective CD8 immunity against influenza infection$454,204
R01 · FY2021 · AI · contact PI
Balancing protective immunity and chronic sequelae by resident CD8 T cells$406,068
R01 · FY2021 · AI · contact PI
Elucidating the roles of alveolar macrophage inflammation and self renewal duringinfluenza infection$270,729
R01 · FY2021 · AG · contact PI
Modeling severe respiratory syncytial virus pathogenesis in bronchopulmonarydysplasia$198,750
R21 · FY2021 · AI · contact PI
Elucidating the roles of alveolar macrophage inflammation and selfrenewal during influenza infection$185,283
R01 · FY2021 · AG · contact PI
Roles of tissue-resident helper T cells in mucosal immunity against influenza infection$124,441
R01 · FY2021 · AI · contact PI
Molecular regulation of protective CD8 immunity against influenza infection$34,283
R01 · FY2021 · AI · contact PI
Balancing protective immunity and chronic sequelae by resident CD8 T cells$565,002
R01 · FY2020 · AI · contact PI
Roles of tissue-resident helper T cells in mucosal immunity against influenza infection$515,015
R01 · FY2020 · AI · contact PI
Mechanisms of influenza viral pathogenesis in normal hosts and hosts with chronic diseases$494,073
R56 · FY2020 · AI · contact PI
Molecular regulation of protective CD8 immunity against influenza infection$488,039
R01 · FY2020 · AI · contact PI
Elucidating the roles of alveolar macrophage inflammation and selfrenewal during influenza infection$456,012
R01 · FY2020 · AG · contact PI
Modeling severe respiratory syncytial virus pathogenesis in bronchopulmonary dysplasia$238,500
R21 · FY2020 · AI · contact PI
COVID-19 competitive revision: BALANCING PROTECTIVE IMMUNITY AND CHRONIC SEQUELAE BY RESIDENT CD8 T CELLS$211,560
R01 · FY2020 · AI · contact PI
Regulation of pulmonary anti-viral immunity in normal and obese hosts$390,000
R01 · FY2019 · HL · contact PI
IRF4 and immunity to influenza infection$389,092
R01 · FY2019 · AI · contact PI
Simultaneously boosting both humoral and cellular immunity following vaccination$325,950
R01 · FY2019 · AG · contact PI
IRF4 and immunity to influenza infection$392,291
R01 · FY2018 · AI · contact PI
Regulation of pulmonary anti-viral immunity in normal and obese hosts$390,000
R01 · FY2018 · HL · contact PI
Simultaneously boosting both humoral and cellular immunity following vaccination$325,950
R01 · FY2018 · AG · contact PI
IRF4 and immunity to influenza infection$403,106
R01 · FY2017 · AI · contact PI
Regulation of pulmonary anti-viral immunity in normal and obese hosts$390,000
R01 · FY2017 · HL · contact PI
Simultaneously boosting both humoral and cellular immunity following vaccination$325,950
R01 · FY2017 · AG · contact PI
Regulation of pulmonary anti-viral immunity in normal and obese hosts$377,506
R01 · FY2016 · HL · contact PI
Simultaneously boosting both humoral and cellular immunity following vaccination$319,800
R01 · FY2016 · AG · contact PI
IRF4 and immunity to influenza infection$288,980
R01 · FY2016 · AI · contact PI
Targeting macrophage Bcl6 to enhance innate resistance to influenza$212,106
R21 · FY2016 · AI · contact PI
IRF4 and immunity to influenza infection$113,996
R01 · FY2016 · AI · contact PI
Regulation of pulmonary anti-viral immunity in normal and obese hosts$12,494
R01 · FY2016 · HL · contact PI
IRF4 and immunity to influenza infection$413,342
R01 · FY2015 · AI · contact PI
Regulation of pulmonary anti-viral immunity in normal and obese hosts$390,000
R01 · FY2015 · HL · contact PI
Simultaneously boosting both humoral and cellular immunity following vaccination$319,800
R01 · FY2015 · AG · contact PI
Targeting macrophage Bcl6 to enhance innate resistance to influenza$234,000
R21 · FY2015 · AI · contact PI
Regulating pulmonary inflammation by type I IFN signaling in neutrophils during i$195,000
R21 · FY2013 · AI · contact PI
Regulating pulmonary inflammation by type I IFN signaling in neutrophils during i$233,500
R21 · FY2012 · AI · contact PI